Based on expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer can be classified into three subtypes, including ER-positive breast cancer, HER2-positive breast cancer, and triple negative breast cancer (TNBC). This evidence concerns the gene PGR and breast carcinoma.